In certain cancer types, a MALAT1–NF-κB axis is involved in chemoresistance and EMT [80,81], and PI3K-AKT signaling has been found to mediate the effect of MALAT1 on metastasis [30,82,83]. Here, AKT1 is linked to cancer.